The role of Mycoplasma in upper respiratory infections

被引:86
作者
Waites K.B. [1 ]
Atkinson T.P. [1 ]
机构
[1] Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35249
关键词
Otitis Medium; Polymerase Chain Reaction Assay; Acute Otitis Medium; Nasal Polyp; Antimicrob Agent;
D O I
10.1007/s11908-009-0030-6
中图分类号
学科分类号
摘要
Mycoplasma pneumoniae is a common cause of upper and lower respiratory tract infections. Pneumonia is the most clinically important manifestation, but tracheobronchitis and various nonspecific upper respiratory tract symptoms are more typically seen in clinical settings. M. pneumoniae can cause pharyngitis with or without concomitant lower respiratory tract involvement, but it is less commonly detected in other upper respiratory conditions such as otitis media, sinusitis, and the common cold. A variety of methods exist for laboratory diagnosis of M. pneumoniae infection, including culture, serology, and the polymerase chain reaction assay, but each has limitations. This article provides a summary of recent studies that have evaluated the role of M. pneumoniae in upper respiratory tract infections; a brief discussion of its cell biology, pathogenic mechanisms, and epidemiology; and recommendations for laboratory diagnosis and management. © Current Medicine Group, LLC 2009.
引用
收藏
页码:198 / 206
页数:8
相关论文
共 49 条
  • [1] Waites K.B., Talkington D.F., Mycoplasma pneumoniae and its role as a human pathogen, Clin Microbiol Rev, 17, pp. 697-728, (2004)
  • [2] Waites K.B., Balish M.F., Atkinson T.P., New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections, Future Microbiol, 3, pp. 635-648, (2008)
  • [3] Atkinson T.P., Balish M.F., Waites K.B., Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections, FEMS Microbiol Rev, 32, pp. 956-973, (2008)
  • [4] Dallo S.F., Baseman J.B., Intracellular DNA replication and long-term survival of pathogenic mycoplasmas, Microb Pathogen, 29, 5, pp. 301-309, (2000)
  • [5] Korppi M., Heiskanen-Kosma T., Kleemola M., Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: Serological results of a prospective, population-based study in primary health care, Respirology, 9, pp. 109-114, (2004)
  • [6] Block S., Hedrick J., Hammerschlag M.R., Et al., Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: Comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate, Pediatr Infect Dis J, 14, pp. 471-477, (1995)
  • [7] Layani-Milon M.P., Gras I., Valette M., Et al., Incidence of upper respiratory tract Mycoplasma pneumoniae infections among outpatients in Rhone-Alpes, France, during five successive winter periods, J Clin Microbiol, 37, pp. 1721-1726, (1999)
  • [8] Marston B.J., Plouffe J.F., File Jr. T.M., Et al., Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group, Arch Intern Med, 157, pp. 1709-1718, (1997)
  • [9] Foy H.M., Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients, Clin Infect Dis, 17, SUPPL. 1, (1993)
  • [10] Makela M.J., Puhakka T., Ruuskanen O., Et al., Viruses and bacteria in the etiology of the common cold, J Clin Microbiol, 36, pp. 539-542, (1998)